HuGE Literature Finder
Records 1-30
|
The Temporal Sequence and the Differences in Somatic Mutation Acquisition Determines Clinical Behaviors of JAK2-Positive Myeloproliferative Neoplasms.
Anticancer research 2019 Nov 39 (11): 6273-6282. Byun Ja Min, Song Seulki, Koh Youngil, Yoon Sung-Soo, Kim Daeyo |
|
Clinical and molecular profile of a Brazilian cohort of patients with classical BCR-ABL1-negative myeloproliferative neoplasms.
Hematology, transfusion and cell therapy 2019 Oct . Porto-Soares Moysés Antonio, de Oliveira Rafael Daltro, Cortopassi Gabriel Macedo, Machado-Neto João Agostinho, Palma Leonardo Carvalho, Figueiredo-Pontes Lorena Lobo |
|
TERT and JAK2 polymorphisms define genetic predisposition to myeloproliferative neoplasms in Japanese patients.
International journal of hematology 2019 Sep . Matsuguma Masafumi, Yujiri Toshiaki, Yamamoto Kaoru, Kajimura Yasuko, Tokunaga Yoshihiro, Tanaka Mayumi, Tanaka Yoshinori, Nakamura Yukinori, Tanizawa Yuk |
|
[Detection and Diagnostic Values of JAK2, CALR, MPL Gene Mutations in 208 Cases of BCR/ABL1 Negative Chronic Myeloproliferative Diseases].
Zhongguo shi yan xue ye xue za zhi 2018 Aug 26 (4): 1122-1128. Li Zhen-Ling, Gao Li, Zhang Hui, Zhang Chun-Xia, Chen Yan-Rong, Huang Fan-Zhou, Gong Ming, Gao Ya-Yue, Tang Yin, Ma Yi-G |
|
Classical Philadelphia-negative myeloproliferative neoplasms: focus on mutations and JAK2 inhibitors.
Medical oncology (Northwood, London, England) 2018 Aug 35 (9): 119. Helbig Grzego |
|
GATA1 Expression in BCR/ABL1-negative Myeloproliferative Neoplasms.
Annals of laboratory medicine 2018 Jul 38 (4): 296-305. Yang Naery, Park Sholhui, Cho Min Sun, Lee Miae, Hong Ki Sook, Mun Yeung Chul, Seong Chu Myong, Huh Hee Jin, Huh Jungw |
|
Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms.
International journal of hematology 2018 Feb . Misawa Kyohei, Yasuda Hajime, Araki Marito, Ochiai Tomonori, Morishita Soji, Shirane Shuichi, Edahiro Yoko, Gotoh Akihiko, Ohsaka Akimichi, Komatsu Nor |
|
Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms.
Annals of hematology 2018 Jan 97 (1): 109-121. Boddu Prajwal, Masarova Lucia, Verstovsek Srdan, Strati Paolo, Kantarjian Hagop, Cortes Jorge, Estrov Zeev, Pierce Sherry, Pemmaraju Nave |
|
Detection of Exon 12 and 14 Mutations in Janus Kinase 2 Gene Including a Novel Mutant in V617F Negative Polycythemia Vera Patients from Pakistan.
Journal of Cancer 2018 9 (23): 4341-4345. Akram Afia Muhammad, Kausar Humera, Chaudhary Asma, Khalid Ahmad Mukhtar, Shahzad Muhammad Mudassar, Akhtar Muhammad Waheed, Sabar Muhammad Farooq, Sajid Nadia, Anazi Nawaf Al, Aleem Aamir, Iqbal Zaf |
|
Effect of CALR and JAK2 mutations on the clinical and hematological phenotypes of the disease in patients with myelofibrosis - long-term experience from a single center.
Neoplasma 2018 65 (2): 296-303. Palova M, Szotkowski T, Hlusi A, Indrak K, Navratilova J, Divoka M, Papajik |
|
CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms.
Hematology (Amsterdam, Netherlands) 2017 Oct 1-4. Ojeda Mara Jorgelina, Bragós Irma Margarita, Calvo Karina Lucrecia, Williams Gladis Marcela, Carbonell María Magdalena, Pratti Arianna Flav |
|
MECOM, HBS1L-MYB, THRB-RARB, JAK2 and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms - a study on 939 patients.
American journal of hematology 2017 Oct . Trifa Adrian P, B?nescu Claudia, Bojan Anca S, Voina Cristian M, Popa ?tefana, Vi?an Simona, Ciubean Alina D, Tripon Florin, Dima Delia, Popov Viola M, Vesa ?tefan C, Andreescu Mihaela, Török-Vistai Tünde, Mih?il? Romeo G, Berbec Nicoleta, Macarie Ioan, Coli?? Andrei, Iordache Maria, C?tan? Alina C, Farca? Marius F, Tomuleasa Ciprian, Vasile Kinga, Truic? Cristina, Todinc? Adriana, Pop-Muntean Lavinia, Manolache Raluca, Bumbea Horia, Vl?d?reanu Ana-Maria, Gaman Mihaela, Ciufu Cristina M, Popp Radu |
|
Germline variations at JAK2, TERT, HBS1L-MYB and MECOM and the risk of myeloproliferative neoplasms in Taiwanese population.
Oncotarget 2017 Sep 8 (44): 76204-76213. Chiang Yi-Hao, Chang Yu-Cheng, Lin Huan-Chau, Huang Ling, Cheng Chun-Chia, Wang Wei-Ting, Cheng Hung-I, Su Nai-Wen, Chen Caleb Gon-Shen, Lin Johnson, Chang Yi-Fang, Chang Ming-Chih, Hsieh Ruey-Kuen, Chou Wen-Chien, Lim Ken-Hong, Kuo Yuan-Y |
|
Germline variations at JAK2, TERT, HBS1L-MYB and MECOM and the risk of myeloproliferative neoplasms in Taiwanese population.
Oncotarget 2017 Jul . Chiang Yi-Hao, Chang Yu-Cheng, Lin Huan-Chau, Huang Ling, Cheng Chun-Chia, Wang Wei-Ting, Cheng Hung-I, Su Nai-Wen, Chen Caleb Gon-Shen, Lin Johnson, Chang Yi-Fang, Chang Ming-Chih, Hsieh Ruey-Kuen, Chou Wen-Chien, Lim Ken-Hong, Kuo Yuan-Y |
|
Comparison of the Mutational Profiles of Primary Myelofibrosis, Polycythemia Vera, and Essential Thrombocytosis.
American journal of clinical pathology 2017 May 147 (5): 444-452. Song Jinming, Hussaini Mohammad, Zhang Hailing, Shao Haipeng, Qin Dahui, Zhang Xiaohui, Ma Zhenjun, Hussnain Naqvi Syeda Mahrukh, Zhang Ling, Moscinski Lynn |
|
Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasms.
Medical oncology (Northwood, London, England) 2017 May 34 (5): 83. Chang Yu-Cheng, Lin Huan-Chau, Chiang Yi-Hao, Chen Caleb Gon-Shen, Huang Ling, Wang Wei-Ting, Cheng Chun-Chia, Lin Johnson, Chang Yi-Fang, Chang Ming-Chih, Hsieh Ruey-Kuen, Chen Shu-Jen, Lim Ken-Hong, Kuo Yuan-Y |
|
Clinical and hematological relevance of JAK2 V617F and CALR mutations in BCR-ABL-negative ET patients.
Hematology (Amsterdam, Netherlands) 2017 Apr 1-8. Limsuwanachot N, Rerkamnuaychoke B, Chuncharunee S, Pauwilai T, Singdong R, Rujirachaivej P, Chareonsirisuthigul T, Siriboonpiputtana |
|
Bone marrow microvessel density and plasma angiogenic factors in myeloproliferative neoplasms: clinicopathological and molecular correlations.
Annals of hematology 2016 Dec . Lekovic Danijela, Gotic Mirjana, Skoda Radek, Beleslin-Cokic Bojana, Milic Natasa, Mitrovic-Ajtic Olivera, Nienhold Ronny, Sefer Dijana, Suboticki Tijana, Buac Marijana, Markovic Dragana, Diklic Milos, Cokic Vladan |
|
Sequential Analysis of 18 Genes in Polycythemia Vera and Essential Thrombocythemia Reveals an Association between Mutational Status and Clinical Outcome.
Genes, chromosomes & cancer 2016 Dec . Luque Paz Damien, Chauveau Aurélie, Boyer Françoise, Buors Caroline, Samaison Laura, Cottin Laurane, Seegers Valérie, Férec Claude, Le Maréchal Cédric, Gueguen Paul, Lippert Eric, Ianotto Jean-Christophe, Ugo Valér |
|
Detection of CALR Mutation in Clonal and Nonclonal Hematologic Diseases Using Fragment Analysis and Next-Generation Sequencing.
American journal of clinical pathology 2016 Oct 146 (4): 448-55. Gardner Juli-Anne, Peterson Jason D, Turner Scott A, Soares Barbara L, Lancor Courtney R, Dos Santos Luciana L, Kaur Prabhjot, Ornstein Deborah L, Tsongalis Gregory J, de Abreu Francine |
|
Coexistence of JAK2 and CALR mutations and their clinical implications in patients with essential thrombocythemia.
Oncotarget 2016 Jul . Min-Gu Kang, Hyun-Woo Choi, Jun Hyung Lee, Yong Jun Choi, Hyun-Jung Choi, Jong-Hee Shin, Soon-Pal Suh, Szardenings Michael, Hye-Ran Kim, Myung-Geun Sh |
|
Detection of JAK2 Exon 12 Mutations in JAK2 V617F-Negative Polycythemia Vera Patients by Cloning Technique.
Acta haematologica 2016 Jul 136 (2): 123-128. Leszczynska Aleksandra, Grzenkowicz-Wydra Jolanta, Chmielewska-Gorycka Lidia, Bieniaszewska Maria, Hellmann Andrz |
|
The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms.
Blood cells, molecules & diseases 2016 Jul 59 25-30. Berzoti-Coelho Maria Gabriela, Ferreira Aline Fernanda, de Souza Nunes Natalia, Pinto Mariana Tomazini, Júnior Maurício Cristiano Rocha, Simões Belinda Pinto, Martínez-A Carlos, Souto Elizabeth Xisto, Panepucci Rodrigo Alexandre, Covas Dimas Tadeu, Kashima Simone, Castro Fabíola Att |
|
Coexisting JAK2V617F and CALR Exon 9 Mutation in Essential Thrombocythemia.
Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2016 Jun 32 (Suppl 1): 112-6. Rashid Munazza, Ahmed Rifat Zubair, Ahmed Shariq, Nadeem Muhammad, Ahmed Nuzhat, Shamsi Tahir Sult |
|
Germline variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms.
Blood 2016 Jun . Hinds David A, Barnholt Kimberly E, Mesa Ruben A, Kiefer Amy K, Do Chuong B, Eriksson Nicholas, Mountain Joanna L, Francke Uta, Tung Joyce Y, Nguyen Huong Marie, Zhang Haiyu, Gojenola Linda, Zehnder James L, Gotlib Jas |
|
Genetic Characteristics of Polycythemia Vera and Essential Thrombocythemia in Korean Patiets.
Journal of clinical laboratory analysis 2016 May . Yoo Eun-Hyung, Park Kyung-Jin, Won Hong-Hee, Park Jun-Hee, Park Jong-Ho, Lee Seung-Tae, Kim Hee-Jin, Bang Soo-Mee, Chi Hyun-Sook, Jung Chul Won, Kim Sun-Hee, Yun Hongseok, Sun Choong-Hyun, Park Inho, Lee Seungmook, Lee Clarence, Merriman Barry, Luo Raymond, Tan Eileen Hwee Hong, Park Keun-Joon, Yoo Na-Kyung, Kang Jason J, Kim Jong-W |
|
Evaluation of the JAK2 V617F mutational status in coronary patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 May 29 (15_suppl): 6585. Gasser K, Muendlein A, Stark N, Winder T, Rein P, Saely C H, Geiger K, Geller-Rhomberg S, Hartmann B L, Kohler B, Drexel H, Lang |
|
Risk of progression to myelofibrosis and acute myeloid leukemia in patients with essential thrombocythemia and polycythemia vera with prior malignancy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 May 29 (15_suppl): 6597. Cherry M A, Pham H, Kantarjian H, Cortes J E, Pierce S, Zhou L, Verstovsek |
|
[Diagnosis of latent polycythemia vera: A clinician's opinion].
Terapevticheskii arkhiv 0 88 (7): 25-30. Melikyan A L, Subortseva I N, Kovrigina A M, Kolosheinova T I, Abdullaev A O, Kuznetsova P I, Sudarikov A B, Kulikov S |
|
Molecular genetics of BCR-ABL1 negative myeloproliferative neoplasms in India.
Indian journal of pathology & microbiology 0 61 (2): 209-213. Rabade Nikhil, Subramanian P G, Kodgule Rohan, Raval Goutham, Joshi Swapnali, Chaudhary Shruti, Mascarenhas Russel, Tembhare Prashant, Gujral Sumeet, Patkar Nikh |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 19, 2021
- Content source: